#161632

1.4E7 cell line

Cat. #161632

1.4E7 cell line

Cat. #: 161632

Sub-type: Hybrid cell line

Organism: Human

Tissue: Pancreas

Disease: Diabetes

Model: Transgenic

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Peter Flatt and Neville McClenaghan

Institute: Ulster University

Primary Citation: Lieber M et al. 1975. Int J Cancer 15: 741-747 PMID: 1140870

Tool Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: 1.4E7 cell line
  • Research fields: Disease (not cancer)
  • Tool sub type: Hybrid cell line
  • Parental cell: PANC-1 cell line
  • Organism: Human
  • Tissue: Pancreas
  • Disease: Diabetes
  • Morphology: Epitheloid
  • Growth properties: Adherent
  • Model: Transgenic
  • Model description: Hybrid cell line formed by the electrofusion of a primary culture of human pancreatic islets with PANC-1, a human pancreatic ductal carcinoma cell line
  • Crispr: No
  • Description: A hybrid cell line formed by the electrofusion of a primary culture of human pancreatic islets with PANC-1, a human pancreatic ductal carcinoma cell line. 1.4E7 has been shown to be tumourigenic when transplanted into a SCID mouse host. The cell line has applications in the study of pancreatic cell biology.
  • Application: producing pure insulin secreting cells when stimulated
  • Additional notes: Patent: Flatt P & McClenaghan N (2004) Insulin producing cell-line US patent number 20040005702 (A1). Also WO0210346 (A2).

Applications

  • Application: producing pure insulin secreting cells when stimulated

Handling

  • Format: Frozen
  • Growth medium: RPMI-1640 + 2mM Glutamine + 10% FCS
  • Temperature: 37° C
  • Atmosphere: 5% CO2
  • Shipping conditions: Dry Ice
  • Storage conditions: Liquid Nitrogen
  • Initial handling information: Split sub-confluent cultures (70-80%) 1:2 to 1:6 i.e. seeding at 2-4 x 104 cells/cmÂ? using 0.05% trypsin or trypsin/EDTA; 5% CO2; 37°C. Population doubling approx 26hrs. At confluence 105 cells/cmÂ? can be expected.
  • Mycoplasma free: Yes
  • Str profiling: STR-PCR Data:Amelogenin: XCSF1PO: 10,12D13S317: 11D16S539: 11D5S818: 11,13D7S820: 8THO1: 7,8TPOX: 8,11vWA: 15

References

  • McCluskey JT et al. 2011. J Biol Chem. Apr 22. PMID: 21515691., Guo-Parke H et al. 2012. J Endocrinol. 214(3):257-65. PMID: 22685334